157 related articles for article (PubMed ID: 10816726)
1. [Role of matrix metalloproteinases in the progression of renal lesions].
Marti HP
Presse Med; 2000 Apr; 29(14):811-7. PubMed ID: 10816726
[TBL] [Abstract][Full Text] [Related]
2. Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
Yurube T; Takada T; Suzuki T; Kakutani K; Maeno K; Doita M; Kurosaka M; Nishida K
Arthritis Res Ther; 2012 Mar; 14(2):R51. PubMed ID: 22394620
[TBL] [Abstract][Full Text] [Related]
3. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
[TBL] [Abstract][Full Text] [Related]
4. Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions.
Zaoui P; Cantin JF; Alimardani-Bessette M; Monier F; Halimi S; Morel F; Cordonnier D
Diabetes Metab; 2000 Jul; 26 Suppl 4():25-9. PubMed ID: 10922970
[TBL] [Abstract][Full Text] [Related]
5. Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring.
Ahmed AK; Haylor JL; El Nahas AM; Johnson TS
Kidney Int; 2007 Apr; 71(8):755-63. PubMed ID: 17290295
[TBL] [Abstract][Full Text] [Related]
6. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
Urushihara M; Kagami S; Kuhara T; Tamaki T; Kuroda Y
Nephrol Dial Transplant; 2002 Jul; 17(7):1189-96. PubMed ID: 12105240
[TBL] [Abstract][Full Text] [Related]
7. The role of matrix metalloproteinases in the activation of mesangial cells.
Marti HP
Transpl Immunol; 2002 May; 9(2-4):97-100. PubMed ID: 12180853
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.
Thrailkill KM; Clay Bunn R; Fowlkes JL
Endocrine; 2009 Feb; 35(1):1-10. PubMed ID: 18972226
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and their inhibitions in experimental renal scarring.
Johnson TS; Haylor JL; Thomas GL; Fisher M; El Nahas AM
Exp Nephrol; 2002; 10(3):182-95. PubMed ID: 12053120
[TBL] [Abstract][Full Text] [Related]
10. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function.
Smith MF; McIntush EW; Ricke WA; Kojima FN; Smith GW
J Reprod Fertil Suppl; 1999; 54():367-81. PubMed ID: 10692869
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and their inhibitors.
Kugler A
Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
[TBL] [Abstract][Full Text] [Related]
13. Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values.
Mäkitalo L; Sipponen T; Kärkkäinen P; Kolho KL; Saarialho-Kere U
Int J Colorectal Dis; 2009 Oct; 24(10):1157-67. PubMed ID: 19652986
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
15. New strategy to treat glomerular inflammation by inhibition of mesangial cell matrix metalloproteinases.
Marti HP
Schweiz Med Wochenschr; 2000 May; 130(21):784-8. PubMed ID: 10904987
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and periodontal diseases.
Sapna G; Gokul S; Bagri-Manjrekar K
Oral Dis; 2014 Sep; 20(6):538-50. PubMed ID: 23849049
[TBL] [Abstract][Full Text] [Related]
17. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
Voloshenyuk TG; Gardner JD
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.
Sekiuchi M; Kudo A; Nakabayashi K; Kanai-Azuma M; Akimoto Y; Kawakami H; Yamada A
Clin Exp Nephrol; 2012 Dec; 16(6):863-74. PubMed ID: 22614167
[TBL] [Abstract][Full Text] [Related]
19. [Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology].
Wasilewska A; Taranta-Janusz K; Zoch-Zwierz W; Rybi-Szumińska A; Kołodziejczyk Z
Przegl Lek; 2009; 66(9):485-90. PubMed ID: 21033407
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.
Zakiyanov O; Kalousová M; Zima T; Tesař V
Adv Clin Chem; 2021; 105():141-212. PubMed ID: 34809827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]